泰恩康：非那雄胺他达拉非胶囊获药品注册证书

Core Viewpoint - The announcement highlights the approval of a new drug, Finasteride and Tadalafil capsules, by the National Medical Products Administration, indicating a significant development for the company in the pharmaceutical sector [1]. Company Summary - Tiancong (301263) announced that its wholly-owned subsidiary, Shandong Huabo Kaisheng Biotechnology Co., Ltd., has received a drug registration certificate for Finasteride and Tadalafil capsules from the National Medical Products Administration [1]. - The new formulation is a combination of Finasteride and Tadalafil, specifically designed to treat the signs and symptoms of benign prostatic hyperplasia in men [1].